Arzneiwerk AG VIDA (FRA:TLIK)
0.2600
-0.0860 (-24.86%)
Jun 3, 2026, 10:23 AM CET
Arzneiwerk AG VIDA Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.02 | 0.13 | 0.08 | 1.49 | 0.39 |
Short-Term Investments | - | - | - | 0.13 | - |
Cash & Short-Term Investments | 0.02 | 0.13 | 0.08 | 1.62 | 0.39 |
Cash Growth | -82.52% | 52.86% | -94.94% | 314.82% | -47.95% |
Accounts Receivable | 0.04 | 0 | 0.04 | 3.48 | 0.35 |
Other Receivables | - | 0.11 | 0 | 0.73 | 0 |
Receivables | 0.04 | 0.11 | 0.04 | 4.21 | 0.35 |
Inventory | - | - | - | 5.18 | 0.01 |
Other Current Assets | 2.92 | 2.38 | 1.6 | 0.11 | 0.09 |
Total Current Assets | 2.98 | 2.62 | 1.72 | 11.13 | 0.84 |
Property, Plant & Equipment | 0 | 0.02 | 0.03 | 2.57 | 0.06 |
Long-Term Investments | 1.53 | 1.53 | 1.53 | 0 | 1.89 |
Other Intangible Assets | - | - | - | 0.58 | - |
Other Long-Term Assets | - | 0 | 0.02 | 0 | 0.05 |
Total Assets | 4.52 | 4.17 | 3.3 | 14.36 | 2.85 |
Accounts Payable | 0.06 | 0.05 | 0.44 | 0.86 | 0.21 |
Accrued Expenses | - | 0.22 | 0.42 | 0.3 | -0 |
Short-Term Debt | - | - | - | 8.75 | - |
Current Portion of Leases | - | - | - | 0.28 | - |
Current Income Taxes Payable | - | 0.01 | 0.01 | 0.66 | 0.01 |
Current Unearned Revenue | - | - | 0 | - | 0.06 |
Other Current Liabilities | 3.92 | 3.88 | 2.43 | 3.58 | 0.84 |
Total Current Liabilities | 3.98 | 4.16 | 3.3 | 14.43 | 1.11 |
Long-Term Debt | - | - | - | 0.89 | - |
Long-Term Leases | - | - | - | 1.1 | - |
Long-Term Unearned Revenue | 0 | 0.01 | 0 | - | 0.13 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.16 | - |
Other Long-Term Liabilities | 0.53 | - | - | -0 | - |
Total Liabilities | 4.52 | 4.17 | 3.3 | 16.58 | 1.24 |
Common Stock | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
Retained Earnings | -7.05 | -7.05 | -7.05 | -21.54 | -4.97 |
Comprehensive Income & Other | 0.81 | 0.81 | 0.81 | 13.09 | 0.35 |
Shareholders' Equity | - | 0 | 0 | -2.22 | 1.61 |
Total Liabilities & Equity | 4.52 | 4.17 | 3.3 | 14.36 | 2.85 |
Total Debt | - | - | - | 11.01 | - |
Net Cash (Debt) | 0.02 | 0.13 | 0.08 | -9.39 | 0.39 |
Net Cash Growth | -82.52% | 52.86% | - | - | -47.95% |
Net Cash Per Share | - | 0.02 | 0.01 | -1.51 | 0.06 |
Filing Date Shares Outstanding | - | 6.23 | 6.23 | 6.23 | 6.23 |
Total Common Shares Outstanding | - | 6.23 | 6.23 | 6.23 | 6.23 |
Working Capital | -1 | -1.54 | -1.58 | -3.3 | -0.27 |
Book Value Per Share | - | - | - | -0.36 | 0.26 |
Tangible Book Value | - | 0 | 0 | -2.81 | 1.61 |
Tangible Book Value Per Share | - | - | - | -0.45 | 0.26 |
Machinery | - | 0.82 | 0.82 | 2.04 | 0.98 |
Order Backlog | - | - | - | - | 1.2 |